ECTRIMS 2019: Alemtuzumab treatment in Denmark

Asta Theodorsdottir | ECTRIMS 2019 | Septttember 12, 2019

Föreläsare: Asta Theodorsdottir

Asta Theodorsdottir prsent data from the The Danish Multiple Sclerosis Registry about the demographics of the alemtuzumab-treated population in Denmark; the treatment strategy; the number of cycles and its relation to previous disease modifying treatments (DMTs); and the frequency of switch to other DMTs.